Pseudonymization of patient identifiers for trans-lational research
The usage of clinical patient data for research im-poses risks concerning privacy and informational self-determination of the patient. The gold standard for safeguarding patients' personal rights is the anonymization of the clinical data. However, next-generation-sequencing technologies and various other methods impose ethical constraints that pro-hibit anonymization of patient samples. Individual results from genetic and genomic research should be offered to study participants in a timely manner. A new method for pseudonymizing patient identifi-ers is presented in which the pseudonymization service provider is unable to derive the patient iden-tifier from the pseudonym, but rather this ability is assigned to an authorized third party (Ombuds-man).
Further Information: PDF
DKFZ (German Cancer Research Center, Deutsches Krebsforschungszentrum)
Phone: +49-6221-42 2955
Contact
Dr. Ruth Herzog
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…